Back
Nektar Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
NKTR
Nektar Therapeutics
Last Price:
$69.11
Seasonality Move:
2.91%
7 Day Trial
ALL ACCESS PASS
$
7
Nektar Therapeutics Stock Forecast
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 43.9% based on the past 31 years of stock performance.
-
Nektar Therapeutics has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%
-
Is Nektar Therapeutics Stock Undervalued?The current Nektar Therapeutics [NKTR] share price is $68.36. The Score for NKTR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 43.9% based on the past 31 years of stock performance.
Nektar Therapeutics Stock Rating
Buy
58
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics overpriced?
-
Nektar Therapeutics has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
75.67
52-Week Low:
6.48
Prediction Charts
Market Cap:
1.2B
Price in USD:
68.36
Volume:
884.8K
Beta:
1.24
Technical Analysis
SMA50:
48.17
SMA100:
53.11
SMA200:
40.37
52-Wk Change:
442.54%
Stock Predictions
-
Is Nektar Therapeutics stock public?Yes, Nektar Therapeutics is a publicly traded company.
-
What is the Nektar Therapeutics stock quote today?The Nektar Therapeutics stock price is 68.36 USD today.
-
How to buy Nektar Therapeutics stock online?You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-10 | 47.15 | 56.00 | 56.76 | 47.05 |
| Feb-11 | 59.00 | 66.35 | 67.94 | 58.95 |
| Feb-12 | 63.33 | 71.00 | 72.31 | 62.00 |
| Feb-13 | 70.48 | 71.33 | 73.37 | 67.70 |
| Feb-17 | 71.44 | 73.82 | 74.89 | 69.85 |
| Feb-18 | 73.50 | 73.18 | 74.87 | 71.31 |
| Feb-19 | 73.30 | 73.86 | 74.84 | 71.72 |
| Feb-20 | 73.99 | 73.73 | 74.83 | 71.50 |
| Feb-23 | 73.50 | 73.62 | 75.67 | 70.66 |
| Feb-24 | 73.88 | 68.42 | 73.88 | 68.20 |
| Feb-25 | 68.35 | 70.37 | 71.94 | 68.35 |
| Feb-26 | 70.00 | 65.90 | 70.99 | 64.50 |
| Feb-27 | 65.10 | 68.98 | 69.29 | 64.78 |
| Mar-2 | 68.14 | 68.36 | 69.56 | 67.00 |
Nektar Therapeutics Earnings
Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Nektar Therapeutics Forecast Revenue Growth
Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $2.76 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.36 per share, and a decrease next year of $2.17 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.